We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSGS icon
76
Madison Square Garden
MSGS
$9.47B
$1.58M 0.24%
7,578
– –
ICAD
77
DELISTED
iCAD Inc
ICAD
$1.58M 0.24%
+415,000
New +$1.38M
GTLS
78
DELISTED
Chart Industries
GTLS
$1.56M 0.24%
+9,450
New +$1.39M
BASE
79
DELISTED
Couchbase
BASE
$1.52M 0.23%
+62,200
New +$1.13M
IPCXU
80
Inflection Point Acquisition Corp III Units
IPCXU
$132M
$1.5M 0.23%
+142,800
New +$1.47M
GYRO icon
81
Gyrodyne
GYRO
$11.8M
$1.49M 0.23%
173,084
– –
COLA
82
Columbus Acquisition Corp
COLA
$48.2M
$1.47M 0.23%
144,700
– –
ITOS
83
DELISTED
iTeos Therapeutics
ITOS
$1.46M 0.22%
+146,450
New +$1.18M
RDFN
84
DELISTED
Redfin
RDFN
$1.45M 0.22%
129,439
-121,265
-48% -$1.19M
CCCXU
85
DELISTED
Churchill Capital Corp X Unit
CCCXU
$1.44M 0.22%
+140,200
New +$1.45M
RIBB
86
Ribbon Acquisition Corp
RIBB
$1.41M 0.22%
+139,200
New +$1.4M
HONE
87
DELISTED
HarborOne Bancorp
HONE
$1.4M 0.22%
+120,186
New +$1.31M
BATRA icon
88
Atlanta Braves Holdings Series A
BATRA
$3.49B
$1.39M 0.21%
28,200
-100
-0.4% -$4.42K
GMS
89
DELISTED
GMS Inc
GMS
$1.37M 0.21%
+12,600
New +$975K
THRD
90
DELISTED
Third Harmonic Bio
THRD
$1.37M 0.21%
+251,681
New +$1.26M
MSFT icon
91
Microsoft
MSFT
$3.74T
$1.35M 0.21%
2,720
– –
BNY
92
Bank of New York Mellon
BNY
$109B
$1.32M 0.2%
14,500
– –
TPL icon
93
Texas Pacific Land
TPL
$25.2B
$1.32M 0.2%
3,750
-30
-0.8% -$12.3K
GCV
94
Gabelli Convertible and Income Securities Fund
GCV
$94.7M
$1.32M 0.2%
344,000
– –
MGRC icon
95
McGrath RentCorp
MGRC
$2.95B
$1.27M 0.19%
10,938
+300
+3% +$33.3K
SBUX icon
96
Starbucks
SBUX
$122B
$1.26M 0.19%
13,800
– –
SIMO icon
97
Silicon Motion
SIMO
$7.6B
$1.26M 0.19%
16,709
-17,850
-52% -$1.01M
DTSQ
98
DT Cloud Star Acquisition Corp
DTSQ
$41.1M
$1.22M 0.19%
232,000
+116,000
+100% +$1.2M
FTW
99
Presidio Production Co
FTW
$338M
$1.21M 0.19%
115,100
– –
META icon
100
Meta Platforms (Facebook)
META
$1.53T
$1.17M 0.18%
1,580
+6
+0.4% +$3.71K
2 3
4
5 6

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.